Parkinson s Disease. Relevant Anatomy (Figure 1):
|
|
- Cecily Johnston
- 7 years ago
- Views:
Transcription
1 BACKGROUND Parkinson s disease, also known as idiopathic paralysis agitans or shaking palsy, is a chronic progressive neurodegenerative disease. Parkinson s disease occurs when a part of the brain which contains dopamine (a certain chemical or neurotransmitter) degenerates. Idiopathic or Classical Parkinson s disease must be differentiated from secondary parkinsonism associated with other neurodegenerative disorders including Olivopontocerebellar degeneration (OPC), Striato-nigral degeneration, Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (Shy-Drager Syndrome). This distinction is important for treatment and predicting response to surgical intervention 1. The combination of resting tremor, initial asymmetry of symptoms, slow progression, and good response to levodopa are most diagnostic of classical Parkinson s. Relevant Anatomy (Figure 1): SIGNS and SYMPTOMS of DISEASE Tremor is often the most prominent clinical symptom. It often starts in one limb and may be worsened by stress, cold weather, or fatigue. It is a tremor present at rest. Bradykinesia is another common symptom. Patients may report slowness with common activities including dressing, bathing, or completing chores 2. Cogwheel rigidity may be seen on exam with a ratchet-like feel of the limb on passive movement. A certain Mask-like facies and a slow and shuffling gait are also seen frequently. Dementia (loss of memory) is also often present as a significant clinical feature of Parkinson s in the elderly. The incidence of dementia in patients with Parkinson s is more than six times greater than in patients without the diagnosis 3. Parkinson s disease affects approximately 1% of Americans over age Age is the single most important risk factor. The male to female ratio is approximately 3:2. No single environmental or genetic factor has been identified but both are believed to play a role in its development 5. A focused exam will help distinguish Idiopathic Parkinson s from other causes of parkinsonism. Abnormalities in vertical eye movement might suggest PSP. Cerebellar features or autonomic instability might suggest Multiple System Atrophy. Early onset (less than age 40) and the presence of Kayser-Fleischer rings on slit-lamp exam would suggest Wilson s disease. DIAGNOSTIC TESTS The diagnosis of Parkinson s is made clinically. Imaging studies may be helpful in distinguishing Idiopathic Parkinson s from other causes of parkinsonism. Page 1 of 6
2 TREATMENT OPTIONS Levodopa the standard medical therapy. Over 90% of patients with Parkinson s initially respond to Levodopa. The absence of a response may suggest an alternative diagnosis. It is contraindicated in patients with malignant melanoma (dopamine is a melanin precursor and may stimulate tumor growth) and in patients taking MAO inhibitors (hypertensive crisis). Nausea and vomiting are common side effects. Dyskinesias (abnormal movements) may be seen. Dopamine Agonists Useful in patients experiencing on-off phenomena and in those requiring larger doses of Levodopa 6. Anticholinergics May improve symptoms of rigidity, tremor and akinesia. Side effects are very common. They include organic confusional syndrome, dry mouth, urinary retention, facial dyskinesias. Anticholinesterase Inhibitors Rivastigmine, a dual cholinesterase inhibitor, showed moderate improvement in dementia associated with Parkinson s disease but was associated with increased nausea, vomiting and tremor in a placebo-controlled study 6. Implantation of Dopaminergic Tissue The first double-blind, placebo-controlled, randomized study of implanted fetal mesencephalic dopaminergic tissue showed no significant difference in any outcome measures between the two groups. Implanted tissue did not reduce the prevalence of dyskinesia and several patients with implanted tissue developed new dyskinesias not relieved by reducing antiparkinsonian medication 7. Deep brain stimulation (DBS) - Electrodes implanted in the brain have been shown to decrease the severity of symptoms during off medication periods, with subsequent reduction of levodopa dosage and associated dyskinesias during on medication periods in patients with advanced Parkinson s 8. A prospective, double-blind study has confirmed these findings 9. This procedure is FDA-approved for treatment of medically refractory Parkinson s. SURGICAL TECHNIQUE Patients may be admitted the night prior to surgery and have anti-parkinson medications withheld on the morning of surgery. A stereotactic frame (smiliar to a HALO) is typically used. MRI of the brain may be used for target planning. Electrodes are implanted under local anesthesia with monitoring. Hair is shaved and the head is prepared in a sterile fashion. Two holes are placed in the skull based on the calculated path. Microelectrodes are advanced through a guide to the anatomical target to aid in determining the final electrode position. The surgery can take 3-6 hours for the implants 10. Xray of DBS Implant in the head (Figure 2) SURGICAL RISKS Recently published data of STN deep brain stimulation suggest that the risks of surgery include device infection (5%), revision (3.1%), cerebral infarct (stroke), bleeding, air embolism, perioperative seizures, confusion (6.8%), and battery failure (8.4%). In a review of 100 patients undergoing STN electrode implantation no patient died or experienced new permanent neurological deficit 14. Page 2 of 6
3 EXPECTED OUTCOME Average hospital stay is approximately 2-3 days including the day prior to surgery. A long-term follow up study of patients who had undergone bilateral subthalamic stimulation demonstrated a 27% improvement in activities of daily living indices and a 28% improvement in motor scores in patients who underwent surgery versus baseline. There was also a greater than 50% reduction in the use of levodopa medication doses 11. A five year prospective study of patients who had undergone bilateral subthalamic nucleus stimulation showed even more promising outcomes. After five-years, patients scores for motor function off medication and for activities of daily living improved by 54 and 49%, respectively. Average scores for cognitive performance and depression, however, did not improve 12. These studies suggest that although there are risks of surgery, in the properly selected patient population deep brain stimulation can provide significant and permanent improvement of Parkinson s related symptoms. AUTHORS S. Yadla, A. Sharan, J. Harrop RELEVANT TERMS (List with Numbers) Deep Brain Stimulation 3. Subthalamic Nucleus Stimulation 4. Levodopa 5. Bradykinesia 6. Substantia Nigra 7. Neostriatum 8. Dyskinesia Page 3 of 6
4 Figure 1: Areas of the Central Nervous System Affected by Parkinson's Disease. Courtesy of Lang AE, Lozano AM.. NEJM 339: , Page 4 of 6
5 Figure 2: An X-ray of the skull showing two deep brain electrodes for Parkinson s disease Page 5 of 6
6 1 Liang, T. Deep Brain stimulation for : Principles of Patient Selection. JHN Journal. 2(1): 2-5, Guttman M, Kish SJ, Furukawa Y. Current Concepts in the Diagnosis and Management of Parkinson s Disease. CMAJ. 168: , Mayeux R, Chen J, Mirabello E, et al. An Estimate of the Incidence of Dementia in Idiopathic. Neurology. 40: , Mitchell SL, Kiely DK, Kiel DP, et al. The Epidemiology, Clinical Characteristics, and Natural History of Older Nursing Home Residents with a Diagnosis of. Journal of the American Geriatric Society. 44: , Lucking CB, Durr A, Bonifati V, et al. Association Between Early-Onset and Mutations in the PARKIN Gene. NEJM. 342: , Emre, M, Aasland, D, Albanese A, et al. Rivastgmine for Dementia Associated with Parkinson s Disease. NEJM. 351: , Greene E, Fahn S. Status of Fetal Tissue transplantation for the Treatment of Advanced Parkinson Disease. Neurosurgical Focus 13: Article 3, Limousin P, Krack P, Pollak P, et al. Electrical Stimulation of the Subthalamic Nucleus in Advanced. NEJM. 339: , The Deep Brain Stimulation for Study Group. Deep-Brain Stimulation of the Subthalamic Nucleus or the Pars Interna of the Globus Pallidus in. NEJM. 345: , Goodman RR, Kim B, McClelland S, et al. Operative Techniques and Morbidity with Subthalamic Nucleus Deep Brain Stimulation in 100 Consecutive Patients with Advanced. Journal of Neurology, Neurosurgery, and Psychiatry. 77: 12-17, Pahwa R, Wilkinson SB, Overman J, Lyons KE. Bilateral Subthalamic Stimulation in Patients with Parkinson Disease: Long-Term Follow Up. Journal of Neurosurgery. 99(1): 71-77, Krack P, Batir A, Van Clercom N, et al. Five-Year Follow-Up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced. NEJM. 349(20): , Page 6 of 6
ABC s of Parkinson s Disease 4/29/15 Karen Parenti, MS, PsyD
ABC s of Parkinson s Disease 4/29/15 Karen Parenti, MS, PsyD What is Parkinson s Disease? Parkinson's disease is a progressive disorder of the nervous system that affects movement. It develops gradually,
More informationParkinson's s disease - a
Parkinson's Disease Parkinson's s disease - a progressive disorder of the nervous system that affects movement. The most common perception of Parkinson s is the patient having tremors. Hands shaking, inability
More informationPARKINSON S DISEASE INTRODUCTION. Parkinson s disease is defined as a disease of the nervous system that affects voluntary movement.
PARKINSON S DISEASE INTRODUCTION Parkinson s disease is a disorder of the brain and the nervous system. It is one of the more common neurological diseases in people over the age of 60, and it is more common
More informationUnderstanding Parkinson s Disease
Understanding Parkinson s Disease Irene Oh, MD Neurologist, Movement Disorders Specialist The Neurology Center of Southern California, Encinitas & Escondido Introduction PD was first described in 1817
More informationPARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS
PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS De Anna Looper, RN CHPN Corporate Clinical Consultant / Legal Nurse Consultant Carrefour Associates L.L.C. PARKINSON S DISEASE IN LONG-TERM-CARE SETTINGS
More informationMr James Garrard University of Leicester May 2014
Parkinson s disease exemplifies the art and science of geriatric medicine. Introduction First described by Dr. James Parkinson in the classic essay The Shaking Palsy in 1817 (1), Parkinson s disease is
More informationParkinson s Disease - A Junior Doctor s Survival Guide
Parkinson s Disease - A Junior Doctor s Survival Guide Professor Richard Walker Consultant Geriatrician Hon. Professor of Ageing & Interna
More informationWhat is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician
What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician Overview of presentation Case history Video example pre and post treatment Historical review PD in the UK Epidemiology and aetiology Making
More informationParkinson's disease. Definition. Symptoms
Parkinson's disease Definition Parkinson's disease is a progressive disorder of the nervous system that affects your movement. It develops gradually, sometimes starting with a barely noticeable tremor
More informationChapter 28. Drug Treatment of Parkinson s Disease
Chapter 28 Drug Treatment of Parkinson s Disease 1. Introduction Parkinsonism Tremors hands and head develop involuntary movements when at rest; pin rolling sign (finger and thumb) Muscle rigidity arthritis
More informationNEUROIMAGING in Parkinsonian Syndromes
NEUROIMAGING in Parkinsonian Syndromes (Focus on Structural Techniques: CT and MRI) Dr. Roberto Cilia Parkinson Institute, ICP, Milan, Italy OUTLINE Primary Parkinsonism Idiopathic Parkinson s Disease
More informationPARKINSON S DISEASE AND PARKINSONISM. Dr Phil Wood Geriatrician, Waitemata DHB Clinical Unit Leader, Waikato DHB
PARKINSON S DISEASE AND PARKINSONISM Dr Phil Wood Geriatrician, Waitemata DHB Clinical Unit Leader, Waikato DHB OUTLINE Covering:- Why this is an important area of Medical and Psychiatric care The variety
More informationPrevalence of Parkinsonism and its aetiological subtypes within patients with movement disorders
Research papers Prevalence of and its aetiological subtypes within patients with movement disorders D G S V D Gajasinghe* AL 2002 batch of students, Faculty of Medicine, University of Colombo Abstract
More informationDisorders Considered. A Brief Synopsis of Select Neurological Disorders. Neurological and Psychiatric Symptoms. Neurological Basis
Disorders Considered A Brief Synopsis of Select Neurological Disorders Four neurological disorders are examined to illustrate pathological conditions that can develop related to course material Myasthenia
More informationParkinson s Disease and Tremors
Parkinson s Disease and Tremors Current Strategies Leah Karliner, MD, MAS Division of General Internal Medicine Disclosures I have no conflicts of interest Parkinsonism neurological syndrome: Bradykinesia:
More informationMotor dysfunction 2: Spinal cord injury and subcortical motor disorders ANATOMY REVIEW: Basal Ganglia
Motor dysfunction 2: Spinal cord injury and subcortical motor disorders ANATOMY REVIEW: Basal Ganglia A group of subcortical nuclei caudate, putamen, globus pallidus Caudate & Putamen = Neostriatum caudate
More informationDementia & Movement Disorders
Dementia & Movement Disorders A/Prof Michael Davis Geriatrician ACT Health & GSAHS ANU Medical School Eastern Dementia Network Aged and Dementia Care Symposium Bateman s Bay, 22 October 2010 Types of Dementia
More informationParkinson s Disease and Dementia. Dr N Samaniego Consultant Physician and Geriatrician
Parkinson s Disease and Dementia Dr N Samaniego Consultant Physician and Geriatrician Case 68 year old female. Off legs for a few months, O/E no neurological deficit. -Slowing down -Needs help with dressing,
More informationAnti-Parkinsonism Drugs
Anti-Parkinsonism Drugs Pharma Team 429 Fahad Alrumaih Ibrahim Alshiddi Sultan Alsalem Ismail Raslan Suhail Asiri Parkinsonism - Could be: primary [idiopathic] or secondary [viral infection or drug induced
More informationManagement in the pre-hospital setting
Management in the pre-hospital setting Inflammation of the joints Two main types: Osteoarthritis - cartilage loss from wear and tear Rheumatoid arthritis - autoimmune disorder Affects all age groups,
More informationLewy body dementia Referral for a Diagnosis
THE Lewy Body society The more people who know, the fewer people who suffer Lewy body dementia Referral for a Diagnosis Lewy Body Dementias REFERRAL FOR A DIAGNOSIS In the UK people with all forms of dementia
More informationParkinson s Disease (PD)
Parkinson s Disease (PD) Parkinson s disease (PD) is a movement disorder that worsens over time. About 1 in 100 people older than 60 has Parkinson s. The exact cause of PD is still not known, but research
More informationDeep Brain Stimulation
Treating Parkinson s Deep Brain Stimulation The surgical treatment of Parkinson s disease (PD) is the result of many decades of neurosurgical innovation, advances in brain imaging and new developments
More informationMeeting the Needs of Aging Persons. Aging in Individuals with a
Meeting the Needs of Aging Persons with Developmental Disabilities Cross Network Collaboration for Florida Aging in Individuals with a Developmental Disability Module 3 Based on ADRC training developed
More informationChad Christine, MD UCSF
Parkinsonism: Clinical Features and Treatments Parkinson's disease is a condition whose main features are slowed movement, tremor, and gait or balance problems. More than1 million people in the United
More informationGLOSSARY OF TERMS. This glossary explains the terms and words often used in association with Parkinson s.
Antagonist This glossary explains the terms and words often used in association with Parkinson s. Medications which have a negative effect on particular cells in the body. In Parkinson s dopamine antagonists
More informationDeep Brain Stimulation for Essential Tremor and Parkinson s Disease (NCD 160.24)
Policy Number Reimbursement Policy 160.24 Approved By UnitedHealthcare Medicare Reimbursement Policy Committee Current Approval Date 06/10/2015 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy
More informationDeep Brain Stimulation(DBS)
Deep Brain Stimulation(DBS) Vancouver General Hospital 899 West 12th Avenue Vancouver BC V5Z 1M9 Tel: 604-875-4111 What is Deep Brain Stimulation? Deep Brain Stimulation is an operation where an electrode
More informationFrequently asked questions: Deep Brain Stimulation for Parkinson's Disease at UCSF
1 Frequently asked questions: Deep Brain Stimulation for Parkinson's Disease at UCSF Contents When should one consider surgical therapy?... 1 What are the different types of surgery for Parkinson's disease?...
More informationSummary of the risk management plan (RMP) for Rasagiline ratiopharm (rasagiline)
EMA/744222/2014 Summary of the risk management plan (RMP) for Rasagiline ratiopharm (rasagiline) This is a summary of the risk management plan (RMP) for Rasagiline ratiopharm, which details the measures
More informationNursing Care of Patients with Movement Disorders. Catholic Health 2 nd Annual Neurorehab Symposium November 1, 2014
Nursing Care of Patients with Movement Disorders Catholic Health 2 nd Annual Neurorehab Symposium November 1, 2014 Types of Movement Disorders Parkinson s disease Huntington s disease Dystonia Tremors
More informationGuide to Deep Brain Stimulation Therapy
Parkinson s Disease: Guide to Deep Brain Stimulation Therapy By: Michael S. Okun, MD Medical Director, National Parkinson Foundation Center of Excellence Co-Director, Center for Movement Disorders and
More informationUnmet Needs for Parkinson s Disease Therapeutics
Unmet Needs for Parkinson s Disease Therapeutics Coalition Against Major Diseases & FDA Workshop October 20, 2014 Caroline M Tanner MD, PhD Director, Parkinson's Disease Research Education and Clinical
More informationParkinson Disease Levodopa-Induced Dyskinesia. Christopher Kenney, MD Novartis Pharmaceuticals
Parkinson Disease Levodopa-Induced Dyskinesia Christopher Kenney, MD Novartis Pharmaceuticals Disclosures Dr. Kenney is a full-time employee of Novartis Pharmaceuticals Corporation The opinions expressed
More informationClinical Research in Parkinson s Disease: The Advances, Challenges, and Importance of Rater Training
Clinical Research in Parkinson s Disease: The Advances, Challenges, and Importance of Rater Training Marian A. Ormont, MD epharmasolutions, A WIRB-Copernicus Group Company April is Parkinson s disease
More informationCholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW
Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Diagnosis of Dementia : DSM-IV criteria Loss of memory and one or more other cognitive abilities Aphasia Apraxia Agnosia
More informationThe majority of parkinsonism (approx. 80%) is due to idiopathic PD other causes include drug therapy (Table 1),toxins and trauma.
THE TREATMENT OF PARKINSON S DISEASE SUMMARY Levodopa (L-dopa) administered in conjunction with a dopa decarboxylase inhibitor (DDCI) remains the mainstay of therapy for Parkinson s disease. New drugs
More informationWelcome to the Medical Risk Webinar: a taster of Assessing and Managing Medical Risk for Insurers courses. 26 April 2013
Welcome to the Medical Risk Webinar: a taster of Assessing and Managing Medical Risk for Insurers courses 26 April 2013 1 Parkinson s Disease & Multiple Sclerosis Dr Nick Niven Jenkins 2 Movement Human
More informationParkinson s Disease: Factsheet
Parkinson s Disease: Factsheet Tower Hamlets Joint Strategic Needs Assessment 2010-2011 Executive Summary Parkinson s disease (PD) is a progressive neuro-degenerative condition that affects a person s
More informationEmergency Room Treatment of Psychosis
OVERVIEW The term Lewy body dementias (LBD) represents two clinical entities dementia with Lewy bodies (DLB) and Parkinson s disease dementia (PDD). While the temporal sequence of symptoms is different
More informationCENTRAL NERVOUS SYSTEM MANAGEMENT OF PARKINSON S DISEASE
MANAGEMENT CENTRAL NERVOUS SYSTEM MANAGEMENT OF PARKINSON S DISEASE Parkinson s Disease is classically determined by the triad or rest tremor (usually starting in one arm) with bradykinesia (slowing of
More informationNeuroStar TMS Therapy Patient Guide for Treating Depression
NeuroStar TMS Therapy Patient Guide for Treating Depression This NeuroStar TMS Therapy Patient Guide for Treating Depression provides important safety and use information for you to consider about treating
More informationCircuit Disorders of the Basal Ganglia: Parkinson s Disease Pathophysiology and Surgical Treatments
Circuit Disorders of the Basal Ganglia: Parkinson s Disease Pathophysiology and Surgical Treatments Mahlon R. DeLong M.D. W. P. Timmie Professor of Neurology Emory University School of Medicine The Basal
More informationA GUIDE FOR THE NEW PATIENT. supported by the Neurological Foundation
PARKINSON S A GUIDE FOR THE NEW PATIENT supported by the Neurological Foundation INTRODUCTION 1 Contents 1. Introduction 2. Parkinson s 3. The main symptoms of Parkinson s 6. What causes Parkinson s? 7.
More informationMultiple System Atrophy
Multiple System Atrophy U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health Multiple System Atrophy What is multiple system atrophy? Multiple system atrophy
More informationSurgery in Individuals Age 65+ Possible Risks. Possible Benefits. Potential Causes of POCD 11/24/2014. What is POCD?
Surgery in Individuals Age 65+ Postoperative Cognitive Dysfunction in Older Adults Ryan W. Schroeder, Psy.D., LP, ABPP-CN Neuropsychologist & Assistant Professor University of Kansas School of Medicine
More informationManagement of Parkinson s Disease in Primary Care
Management of Parkinson s Disease in Primary Care Dr June Tan National University Hospital System (NUHS) Division of Neurology Senior Consultant Topics: Diagnosing PD Choice of medication in the de novo
More informationSinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022
Brochure More information from http://www.researchandmarkets.com/reports/2834728/ Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022 Description: Sinemet (Parkinson s Disease) - Forecast
More informationClinical and Therapeutic Cannabis Information. Written by Cannabis Training University (CTU) All rights reserved
Clinical and Therapeutic Cannabis Information Written by Cannabis Training University (CTU) All rights reserved Contents Introduction... 3 Chronic Pain... 6 Neuropathic Pain... 8 Movement Disorders...
More informationSleep Difficulties. Insomnia. By Thomas Freedom, MD and Johan Samanta, MD
Sleep Difficulties By Thomas Freedom, MD and Johan Samanta, MD For most people, night is a time of rest and renewal; however, for many people with Parkinson s disease nighttime is a struggle to get the
More informationIII./3.1.2. Parkinsonian syndrome (parkinsonism, atypical parkinsonian disorders) in neurodegenerative diseases
III./3.1.2. Parkinsonian syndrome (parkinsonism, atypical parkinsonian disorders) in neurodegenerative diseases III./3.1.2.1. Multiple System Atrophy (MSA) MSA is a sporadic, adult onset degenerative neurological
More informationX-Plain Trigeminal Neuralgia Reference Summary
X-Plain Trigeminal Neuralgia Reference Summary Introduction Trigeminal neuralgia is a condition that affects about 40,000 patients in the US every year. Its treatment mostly involves the usage of oral
More informationParkinsonism is an umbrella term used to cover a range of conditions.
Symptoms and lifestyle Parkinsonism Parkinsonism is an umbrella term used to cover a range of conditions. These conditions share the symptom of slow movement, sometimes with tremor, rigidity and problems
More informationEBM Parkinson s Diseases
Parkinson s Diseases Version 1 Final Page 1 Document control Version history Version Date Comments 1e (draft) 30 March 2007 Comments from customer incorporated 1d (draft) 22 January 2007 Formatting 1c
More informationAmino Acid Therapy to Restore Neurotransmitter Function
Amino Acid Therapy to Restore Neurotransmitter Function Alvin Stein, MD Neurotransmitters are chemicals manufactured by our bodies that allow our nervous system to function properly. When the body requires
More informationPersonal Health Record
Personal Health Record Contents Section 1: Personal details (pages 4 6) Within this section you can note all information about you, next of kin, important health information and general medical history.
More informationChapter 18 Drugs Used for Psychoses Learning Objectives Identify signs and symptoms of psychotic behavior Describe major indications for the use of
Chapter 18 Drugs Used for Psychoses Learning Objectives Identify signs and symptoms of psychotic behavior Describe major indications for the use of antipsychotic agents Identify common adverse effects
More informationBrain Cancer. This reference summary will help you understand how brain tumors are diagnosed and what options are available to treat them.
Brain Cancer Introduction Brain tumors are not rare. Thousands of people are diagnosed every year with tumors of the brain and the rest of the nervous system. The diagnosis and treatment of brain tumors
More informationSLEEP DIFFICULTIES AND PARKINSON S DISEASE Julie H. Carter, R.N., M.S., A.N.P.
SLEEP DIFFICULTIES AND PARKINSON S DISEASE Julie H. Carter, R.N., M.S., A.N.P. Problems with sleep are common in Parkinson s disease. They can sometimes interfere with quality of life. It is helpful to
More informationSO, YOU ARE HAVING DBS SURGERY?
SO, YOU ARE HAVING DBS SURGERY? This resource is for Awake Deep Brain Stimulation (DBS) patients. Welcome to Brigham and Women s Hospital and the Deep Brain Stimulation (DBS) Program Serving patients in
More informationPart 1 of a 6-Part Series
Release Date: April 1, 2003. Termination Date: April 1, 2004. Estimated time to complete this 6-part newsletter series: 3.0 hours. For additional updates, go to www.projectsinknowledge.com Awake and Involved:
More informationTraumatic brain injury (TBI)
Traumatic brain injury (TBI) A topic in the Alzheimer s Association series on understanding dementia. About dementia Dementia is a condition in which a person has significant difficulty with daily functioning
More informationWhat s New in Multiple Sclerosis and Parkinson Disease?
What s New in Multiple Sclerosis and Parkinson Disease? Eric S. Farbman, MD University of Nevada School of Medicine Division of Neurology Director of Movement Disorders Center Disclosures Member of Parkinson
More informationCerebral palsy can be classified according to the type of abnormal muscle tone or movement, and the distribution of these motor impairments.
The Face of Cerebral Palsy Segment I Discovering Patterns What is Cerebral Palsy? Cerebral palsy (CP) is an umbrella term for a group of non-progressive but often changing motor impairment syndromes, which
More informationPARKINSONISM. akinetic-rigid syndrome
PARKINSONISM PARKINSONISM akinetic-rigid syndrome PARKINSONISM Symptoms of Parkinson s disease: akinesia, bradykinesia, rigidity, postural instability, gait impairment, tremor A common, age-related syndrome
More informationMore information >>> HERE <<<
More information >>> HERE http://urlzz.org/hearloss/pdx/dcli864/ Tags: ## best way to get cheapest natural methods to
More informationAn Introduction to Lewy Body Dementia
An Introduction to Lewy Body Dementia A special publication for people newly diagnosed with Lewy body dementia and those still seeking answers. You don t have to face LBD alone. Increasing Knowledge Sharing
More informationNeurological System Best Practice Documentation
Neurological System Best Practice Documentation Click on the desired Diagnoses link or press Enter to view all information. Diagnoses: Dementia Delirium/Encephalopathy Parkinson s Epilepsy /Seizure Migraines
More informationMultiple System Atrophy guide (http://www.msaweb.co.uk/msaguide.htm)
Multiple System Atrophy guide (http://www.msaweb.co.uk/msaguide.htm) Accessing information on Multiple System Atrophy (MSA) can be hard work. The Sarah Matheson Trust (SMT) produces a guide to MSA that
More informationElectroconvulsive Therapy - ECT
Electroconvulsive Therapy - ECT Introduction Electroconvulsive therapy, or ECT, is a safe and effective treatment that may reduce symptoms related to depression or mental illness. During ECT, certain parts
More information2.0 Synopsis. Vicodin CR (ABT-712) M05-765 Clinical Study Report R&D/07/095. (For National Authority Use Only) to Part of Dossier: Volume:
2.0 Synopsis Abbott Laboratories Name of Study Drug: Vicodin CR Name of Active Ingredient: Hydrocodone/Acetaminophen Extended Release (ABT-712) Individual Study Table Referring to Part of Dossier: Volume:
More informationF r e q u e n t l y A s k e d Q u e s t i o n s
Myasthenia Gravis Q: What is myasthenia gravis (MG)? A: Myasthenia gravis (meye-uhss- THEEN-ee-uh GRAV uhss) (MG) is an autoimmune disease that weakens the muscles. The name comes from Greek and Latin
More informationDepression. Introduction Depression is a common condition that affects millions of people every year.
Depression Introduction Depression is a common condition that affects millions of people every year. Depression has an impact on most aspects of everyday life. It affects eating and sleeping routines,
More information1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136. Days and Hours: Monday Friday 8:30a.m. 6:00p.m. (305) 355 9028 (JMH, Downtown)
UNIVERSITY OF MIAMI, LEONARD M. MILLER SCHOOL OF MEDICINE CLINICAL NEUROPSYCHOLOGY UHEALTH PSYCHIATRY AT MENTAL HEALTH HOSPITAL CENTER 1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136 Days and Hours:
More informationRecognition and Treatment of Depression in Parkinson s Disease
Recognition and Treatment of Depression in Parkinson s Disease Web Ross VA Pacific Islands Health Care System What is depression? Depression is a serious medical condition that affects a person s feelings,
More information9/20/2010. The eye doesn t see what the mind doesn t know. Sir William Osler
The eye doesn t see what the mind doesn t know. Sir William Osler Lewy Body Dementia Atypical Dementia The Lewy Body Spectrum Patricia J. Gifford, MD Silverado Hospice 2009 Progressive loss of intellectual
More informationChemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015
Chemobrain Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015 Terminology Chemotherapy-associated cognitive dysfunction Post-chemotherapy cognitive impairment Cancer treatment-associated cognitive
More informationPrimary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment
Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Kinga Szigeti, MD Associate Professor UBMD Neurology UB Department of Neurology Questions How do we differentiate
More informationDiagnosis and Treatment of Parkinson s Disease: A Systematic Review of the Literature
Evidence Report/Technology Assessment Number 57 Diagnosis and Treatment of Parkinson s Disease: A Systematic Review of the Literature Prepared for: Agency for Healthcare Research and Quality U.S. Department
More informationSocial Security Disability Insurance and young onset dementia: A guide for employers and employees
Social Security Disability Insurance and young onset dementia: A guide for employers and employees What is Social Security Disability Insurance? Social Security Disability Insurance (SSDI) is a payroll
More information---------------------
EVERYTHING YOU NEED TO KNOW ABOUT PARKINSON S DISEASE --------------------- THE TOP 101 QUESTIONS ABOUT PARKINSON S DISEASE By Lianna Marie Copyright 2005 Lianna Marie All rights reserved. No part of this
More informationDisease Surveillance in New Jersey Spring 2006
Creutzfeldt-Jakob Disease Surveillance in New Jersey Spring 2006 Shereen Brynildsen, MS Epidemiologist, Infectious & Zoonotic Disease Program New Jersey Department of Health & Senior Services Phone: 609-588
More informationPallidotomy and Thalamotomy
Pallidotomy and Thalamotomy Vancouver General Hospital 899 West 12th Avenue Vancouver BC V5Z 1M9 Tel: 604-875-4111 This booklet will provide information about the following surgical procedures: Pallidotomy
More informationHeadaches and Kids. Jennifer Bickel, MD Assistant Professor of Neurology Co-Director of Headache Clinic Children s Mercy Hospital
Headaches and Kids Jennifer Bickel, MD Assistant Professor of Neurology Co-Director of Headache Clinic Children s Mercy Hospital Overview Headache classifications and diagnosis Address common headache
More informationBrain Tumor Treatment
Scan for mobile link. Brain Tumor Treatment Brain Tumors Overview A brain tumor is a group of abnormal cells that grows in or around the brain. Tumors can directly destroy healthy brain cells. They can
More informationSupportive Care For Patients With High-Grade Glioma (primary brain tumours) Dr Susan Catt & Professor Lesley Fallowfield
Supportive Care For Patients With High-Grade Glioma (primary brain tumours) Dr Susan Catt & Professor Lesley Fallowfield Partners Mr Giles Critchley Consultant Neurosurgeon Hurstwood Park Neurological
More informationPARKINSON'S DISEASE The Disorder and Current Therapy Copyright 2008, Daniel Kassicieh, D.O.
PARKINSON'S DISEASE The Disorder and Current Therapy Copyright 2008, Daniel Kassicieh, D.O. Parkinson's disease is a common neurologic disorder. It affects people of all ages and ethnic backgrounds and
More informationMental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca
Mental health issues in the elderly January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca Cognitive Disorders Outline Dementia (294.xx) Dementia of the Alzheimer's Type (early and late
More informationClinical Psychopharmacology
Clinical Psychopharmacology Antiparkinsonian drugs Department of Pharmacy, GGZ WNB Chair on Pharmacotherapy in Psychiatric Patients/Anton Loonen May 2015 2 Basal ganglia diseases Parkinson s disease and
More informationCurrent evidence suggests that Parkinson s tends to develop
About Parkinson's Diagnosing Parkinson s Current evidence suggests that Parkinson s tends to develop gradually and it may be many months, even years, before the symptoms become obvious enough for you to
More informationHospital-based SNF Coding Tip Sheet: Top 25 codes and ICD-10 Chapter Overview
Hospital-based SNF Coding Tip Sheet: Top 25 codes and Chapter Overview Chapter 5 - Mental, Behavioral and Neurodevelopmental Disorders (F00-F99) Classification improvements (different categories) expansions:
More informationAlzheimer's: The Latest Assessment and Treatment Strategies
Questions from chapter 1 Alzheimer's: The Latest Assessment and Treatment Strategies 1) What is a loss of cognitive and intellectual powers without changes in consciousness. a) dementia b) delusions c)
More informationVNS Therapy for Epilepsy
VNS Therapy for Epilepsy This pamphlet provides general information for the public. It is not intended to cover all possible uses, directions, precautions, interactions or adverse effects involving any
More informationParkinson s Disease: General Information
Parkinson s Disease: General Information Does PD come in stages? If so, how many stages? Hubert Fernandez, MD: Staging provides an artificial classification of a patient's illness severity but, in reality,
More informationFollow-up Form B3: Evaluation Form Unified Parkinson s Disease Rating Scale (UPDRS 1 ) Motor Exam
phone: (206) 543-8637; fax: (206) 616-5927 e-mail: naccmail@u.washington.edu website: www.alz.washington.edu NACC Uniform Data Set (UDS) Follow-up Form B3: Evaluation Form Unified Parkinson s Disease Rating
More informationCerebellum and Basal Ganglia
Cerebellum and Basal Ganglia 1 Contents Cerebellum and Basal Ganglia... 1 Introduction... 3 A brief review of cerebellar anatomy... 4 Basic Circuit... 4 Parallel and climbing fiber input has a very different
More information1: Motor neurone disease (MND)
1: Motor neurone disease (MND) This section provides basic facts about motor neurone disease (MND) and its diagnosis. The following information is an extracted section from our full guide Living with motor
More informationPHYSICAL THERAPY ASSISTANT PROGRAM (Associate in Applied Science, AAS)
PHYSICAL THERAPY ASSISTANT PROGRAM (Associate in Applied Science, AAS) ADMISSION PROCEDURES To be admitted to the Physical Therapy Assistant Program (AAS), a prospective student must be interviewed by
More informationDepression in Older Persons
Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression
More informationTaking care of tomorrow
Friends Life Protection Account Critical Illness Cover Guide Taking care of tomorrow Critical Illness Cover Taking care of tomorrow Friends Life Critical Illness Cover is here for you through whichever
More information